Skip to main content

Table 4 Comparison of changes in lab results between the progression and non-progression groups

From: Insulin resistance predicts progression of de novo atherosclerotic plaques in patients with coronary heart disease: a one-year follow-up study

Difference value of Variables

Progression group

(n = 198)

Non-progression group

(n = 168)

p value

Glucose

0.21 ± 2.20

−0.19 ± 1.27

0.136

OGTT

−0.42 ± 3.92

−0.67 ± 2.87

0.025

Insulin

6.00 ± 23.46

2.42 ± 11.90

0.347

Insulin2h

20.75 ± 58.80

14.65 ± 49.81

0.200

SBP

−6.80 ± 21.76

2.68 ± 19.54

0.327

DBP

−5.65 ± 11.95

−1.58 ± 13.80

0.637

PP

−1.15 ± 18.76

4.26 ± 15.99

0.925

MAP

−6.03 ± 13.22

−0.16 ± 14.05

0.517

HbA1c

0.17 ± 1.28

0.02 ± 0.97

0.339

hsCRP

−4.61 ± 18.68

−11.19 ± 21.90

0.659

BUN

0.22 ± 1.39

0.48 ± 1.85

0.525

Creatinine

3.33 ± 16.63

4.28 ± 10.42

0.948

UA

20.25 ± 49.91

41.06 ± 70.41

0.311

GFR

−3.17 ± 12.38

−5.90 ± 14.05

0.520

Urine Malb/Cr

0.89 ± 66.12

0.20 ± 1.83

0.491

TG

−0.29 ± 0.91

−0.36 ± 1.58

0.279

TC

−0.90 ± 0.91

−0.57 ± 1.09

0.285

LDL

0.16 ± 0.43

0.16 ± 0.30

0.321

HDL

0.02 ± 0.22

0.06 ± 0.21

0.124

Lpa

−0.01 ± 0.09

0.14 ± 0.59

0.114

ApoA

0.02 ± 0.23

0.11 ± 0.25

0.919

ApoB

−0.09 ± 0.26

−0.08 ± 0.23

0.609

LVEF

−1.05 ± 5.65

−0.43 ± 5.83

0.561

  1. We calculate the changes in laboratory results by deducting the index value from the follow-up value.
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840